These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 11968343

  • 21. Review article: predicting response in hepatitis C virus therapy.
    Mihm U, Herrmann E, Sarrazin C, Zeuzem S.
    Aliment Pharmacol Ther; 2006 Apr 15; 23(8):1043-54. PubMed ID: 16611264
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Treatment of hepatitis C: therapeutic management].
    Bourliere M.
    Gastroenterol Clin Biol; 2008 May 15; 32(5 Pt 2):S166-71. PubMed ID: 18482813
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
    Hofer H, Osterreicher C, Jessner W, Penz M, Steindl-Munda P, Wrba F, Ferenci P.
    J Hepatol; 2004 Jun 15; 40(6):1018-22. PubMed ID: 15158344
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluating the evidence from clinical trials in chronic hepatitis C.
    Brown RS.
    J Viral Hepat; 2006 May 15; 13 Suppl 1():15-25. PubMed ID: 16630043
    [Abstract] [Full Text] [Related]

  • 30. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
    Cornberg M, Hadem J, Herrmann E, Schuppert F, Schmidt HH, Reiser M, Marschal O, Steffen M, Manns MP, Wedemeyer H.
    J Hepatol; 2006 Feb 15; 44(2):291-301. PubMed ID: 16360972
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML, Lin SM, Chuang WL, Dai CY, Wang JH, Lu SN, Sheen IS, Chang WY, Lee CM, Liaw YF.
    Antivir Ther; 2006 Feb 15; 11(8):985-94. PubMed ID: 17302368
    [Abstract] [Full Text] [Related]

  • 36. Doing battle with HCV.
    Fimmel CJ.
    Am J Gastroenterol; 2000 Mar 15; 95(3):582-3. PubMed ID: 10710043
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of chronic hepatitis C in patients with renal disease.
    Gane E.
    Med J Malaysia; 2005 Jul 15; 60 Suppl B():72-6. PubMed ID: 16108179
    [No Abstract] [Full Text] [Related]

  • 39. Hepatitis C: not so indolent in survivors of pediatric cancer?
    Schwarz KB.
    Pediatr Blood Cancer; 2010 Jul 15; 55(1):7. PubMed ID: 20486163
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.